Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics

Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics

The purpose of this study was to identify clinician characteristics associated with higher prescription rates of long-acting injectable (LAI) antipsychotics, as well as the sources that influence medical decision-making regarding the treatment of schizophrenia. We surveyed 202 psychiatrists during s...

Full description

Bibliographic Details
Main Authors: Ludovic Samalin, Marion Garnier, Candy Auclair, Pierre-Michel Llorca
Format: Article
Language:English
Published: MDPI AG 2016-11-01
Series:International Journal of Molecular Sciences
Subjects:
long-acting injectable
antipsychotic
decision-making
guidelines
schizophrenia
Online Access:http://www.mdpi.com/1422-0067/17/11/1935

Internet

http://www.mdpi.com/1422-0067/17/11/1935

Similar Items